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We compared the performance of the Whole, Turret and Step
techniques of 100% rapid rescreening (RR) in detection of false-
negatives in cervical cytology. We tested RR performance with
cytologists trained and among those without training. We revised
1,000 consecutive slides from women participating in an
ongoing international screening trial. Two teams of experienced
cytologists performed the RR techniques: one trained in RR pro-
cedures and the other not trained. The sensitivities in the trained
group were Whole 46.6%, Turret 47.4% and Step 50.9%; and in
the non-trained group were 38.6, 31.6 and 47.4%, respectively.
The j coefﬁcient showed a weak agreement between the two
groups of cytologists and between the three RR techniques. The
RR techniques are more valuable if used by trained cytologists.
In the trained group, we did not observe signiﬁcant differences
between the RR techniques used, whereas in the non-trained
group, the Step technique had the best sensitivity. Diagn. Cyto-
pathol. 2007;35:57–60. ' 2006 Wiley-Liss, Inc.
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Well-conducted programs for cervical cancer prevention
based on cytology screening are successful in many coun-
tries, with markedly decreased incidence and mortality
rates.1–3 Despite the Papanicolaou test (Pap test) triumph
as an inexpensive and efﬁcient method, high false-nega-
tive rates have hampered its performances worldwide.4,5
Cytological screening is a complex repetitive and
monotonous activity that depends on special skill of the
professionals involved in the screening, including good
concentration and posture, to support sometimes an exces-
sive and stressing workload.6 It is not surprising that
errors can occur when a human being is subjected to an
extreme pressure. Consequently, false-negative rates can
increase.7,8 During the past years, several measures have
been introduced to control the quality of the cytologists,
including internal and external quality assurance (QA),
and automated pre-and post-screening; the last mentioned
is likely to be too costly for most countries.
The rapid rescreening (RR) was introduced in 1991 by
Baker e Melcher,7 using ‘‘Turret pattern’’ to rapidly screen
the routine slides. The method proved successful in picking
up abnormal cervical smears. Subsequently, other optional
RR techniques have been introduced. The Step technique
and random paths have been used, and some laboratories
have attempted to rescreen the whole slide quickly.9 Faraker
introduced the Step technique in 1993,10 and he was able to
identify 92% of the dyskaryotic smears seeded into a series
of 500 cases. The advantage of the Step and Turret methods
is that the cytologist is screening at regular speed and thus
likely to detect the abnormal cells in the path. The strength
of the Whole slide screening is that all or most of the mate-
rial is covered, although obviously at fairly high speed.11
Dudding and colleagues9 obtained their best results using
Step, whereas others reported that Turret was superior in
identifying cellular abnormalities missed in the primary
screening.11
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RR is believed to be superior to random revision of
10% of negative cases. We have recently compared both
methods and observed that the sensitivity in detecting
false-negative smears was 73.5% for RR and 40.9% for
the random 10% method. On the other hand, the speciﬁc-
ity was identical for both 98.6 and 98.8%, respectively.12
The aim of our work was pivotal. First to evaluate
whether the Whole, Turret and Step techniques performed
differently in identifying false-negative slides. Further-
more, we tested whether this performance depends on
experience, by comparing the test performance in two
groups of experienced cytologists: one group trained for
RR and the other group not trained for RR procedures.
Methods
We evaluated 1,000 consecutive cytological smears from
women examined between February 2002 and September
2003 at Cytology Laboratory of State University of Cam-
pinas (UNICAMP) while participating in the ongoing
LAMS (Latin America Screening) study, supported by
European Commission (Project No. ICA4-CT-2001-
10013). All conventional Pap smears were collected with
Ayre’s spatula and endocervical brush, placed on one
slide and prepared according to traditional methods.
General Characteristics of the RR Reviewers
The slides were reviewed by two groups of experienced
cytologists, three in each group, working at the UNICAMP
Cytology Laboratory (CAISM), designated in this study as
Laboratory A, and at the Division of Pathology, Adolfo
Lutz Institute (IAL), designated as Laboratory B. Both labo-
ratories have equal expertise in cervical cytology. Labora-
tory A is responsible for screening of 300,000 Pap tests
annually, and Laboratory B is a reference centre for quality
control of cytopathology in the Sa˜o Paulo State Health
Authorities, and a centre of research in cytopathology. The
reviewers from Laboratory A were previously trained for
RR procedures during 3 mo before the study (1 mo for each
technique: Whole, Turret and Step). Conversely, the mem-
bers of Laboratory B were not formerly trained, but only
received a brief introduction to these techniques.
The Test Samples
All reviewers rescreened 1,000 slides distributed in three
sets as follows: 333, 333 and 334 slides in each set. The
sets were exchanged between the reviewers, who exam-
ined all cases in a blinded manner.
One experienced cytopathologist made a regular review
of every smear after the RR procedures, and negative
smears in both revisions were assumed as true negatives
for statistical purpose. A second senior cytopathologist
reviewed integrally all the smears reported as suspicious
by RR and also those referred as abnormal by the ﬁrst
cytopathologist. The ﬁnal diagnosis was reached at a con-
sensus meeting of both cytopathologists using consultation
microscope, and these diagnoses were treated as the gold
standard. The diagnoses were reported using the revised
Bethesda System.13 In RR, the smears were classiﬁed as
negative, suspicious or unsatisfactory.
The Methods of Rescreening
The principles of the three RR procedures are depicted in
Figures 1–3. The duration of each RR procedure was
1 min per smear, and 15-sec intervals throughout the
study, with a designated member of staff controlling the
time rigorously. It was decided that the ﬁelds of a slide
were screened using 103 magniﬁcation.
Performance Indicators
Sensitivity and speciﬁcity with their respective 95% conﬁ-
dence intervals (95% CI) were calculated for the three
Fig. 1. The Whole technique: the observer reads the slide in horizontal
direction.
Fig. 2. The Turret technique: the observer runs the slide in horizontal
and vertical (Greek bar) sense alternatively.
Fig. 3. The Step technique: the observer runs the slide in a stair-wise
fashion.
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RR techniques. The positive (PPV) and negative predic-
tive values (NPV) were also calculated. As truly positive
cases were regarded, all slides were classiﬁed as suspi-
cious in RR and conﬁrmed positive by the cytopatholo-
gist’s examination. False-negative smears were all those
classiﬁed as negative in RR but found to be abnormal by
the two cytopathologists.
Results
Table I shows the ﬁnal diagnosis of the 1,000 slides ana-
lysed by cytopathologists, and used as the gold standard
for performance calculations.
Tables II and III show the performance of the three RR
techniques in hands of the teams in Laboratory A and B.
The team trained for RR (Table II) reached sensitivity
slightly superior to that of the non-trained team (Table
III), although relatively low in both the laboratories. On
the other hand, there were no signiﬁcant differences in
the other parameters between the two groups.
Tables IV and V show that negative and HSIL results
were reproducible among the three RR techniques and
between the two teams. The majority of cases classiﬁed
as normal by RR and shown to be abnormal in the ﬁnal
diagnosis proved to be ASC-US.
Table VI shows the reproducibility of the three RR tech-
niques in the two teams. The concordance between the three
methods was only weak (j between 0.2 and 0.4), and the
values were practically identical for both teams, never
reaching the 0.4 limit of moderate reproducibility.
Discussion
Pap test has played an important role in cervical cancer
prevention. Despite the undeniable achievements obtained
in reduction of cervical cancer incidence and mortality in
counties with organised screening programme, the high
false-negative rates remain a concern among the Public
Health authorities.4 The inherent false-negative rate of the
Pap test has prompted the design of different strategies
how to avoid false diagnoses, including the RR meth-
ods.14 These false-negative rates are estimates to exceed
20% in some laboratories with sub-optimal performance.5
Such a high probability of screening errors has encour-
aged us to apply RR methods in daily routine to reduce
the number of missed cases with signiﬁcant abnormal-
ity.12 Our previous experience suggested that a slightly
higher sensitivity was reached by the teams of formerly
trained cytologists, making us to speculate that the RR
techniques are dependent on training,12 which was tested
in the present study.
The present data show that of the three RR techniques
tested, the Step method showed performance somewhat
superior to that of the Whole and Turret methods, in the
hands of both teams (trained and non-trained). The exact
reasons explaining this difference remain to be clariﬁed in
the future studies, but at this stage, we speculate that the
regularity of the hand movements and the constant velocity
of the Step method might offer more optimal conditions for
the observer to trace the cells with subtle alterations. On the
other hand, because the speed of the other two procedures is
higher due to the more simple hand movements, we antici-
pate that this higher velocity contributes to the higher rate
of missed cases in the Whole and Turret methods, as com-
pared with the Step procedure. When measured using the j
statistics, the agreement between the three RR methods was
only weak, and never reached even the lower boundary of
Table II. Results of the Whole, Turret and Step Techniques in the
Laboratory A
Technique
Sensitivity
(CI 95%)
Speciﬁcity
(CI 95%) PPV NPV
Whole 46.6 (33.3–60.1) 92.3 (90.4–93.9) 27.8 96.4
Turret 47.4 (34.0–61.0) 94.8 (93.1–96.1) 36.5 96.6
Step 50.9 (37.3–64.4) 94.3 (92.6–95.7) 36.3 96.8
CI, conﬁdence interval; PPV, positive predictive value and NPV, nega-
tive predictive value.
Table III. Results of the Whole, Turret and Step Techniques in the
Laboratory B
Technique
Sensitivity
(CI 95%)
Speciﬁcity
(CI 95%) PPV NPV
Whole 38.6 (26.0–52.4) 96.4 (94.9–97.5) 40.0 96.1
Turret 31.6 (19.9–45.2) 97.9 (96.7–98.7) 48.6 95.8
Step 47.4 (34.0–60.3) 96.5 (95.0–97.6) 45.8 96.7
CI, conﬁdence interval; PPV, positive predictive value and NPV, nega-
tive predictive value.
Table IV. Distribution of the Diagnoses With the Three RR
Techniques in Laboratory A
Final
diagnosis
Whole/Turret/Step–Laboratory A
Negative Suspicious
n % n %
Negative 838/854/843 92/95/94 70/47/51 8/5/6
LSIL 3/4/5 27/36/45 8/7/6 73/64/54
HSIL –a –a 8/8/8 100
AGC 4/3/0 100/75/0 0/0/4 0/0/100
ASC-US 24/23/23 71/67/70 10/11/10 29/32/30
ASC-H –a –a 1/1/1 100
aThe three techniques detected all HSIL and ASC-H cases in the Labora-
tory A.
Table I. Consensus Diagnoses of the 1,000 Test Slides Subjected to
Rescreening
Diagnosis n %
Negative 931 93.1
ASC-US 34 3.4
ASC-H 1 0.1
LSIL 11 1.1
HSIL 8 0.8
AGC 4 0.4
Unsatisfactory 11 1.1
Total 1,000 100
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the moderate agreement (j ¼ 0.4) (Table VI). This inter-
technique reproducibility did not depend on the training sta-
tus of the cytologists.
In the present study, we detected 87–100% of the HSIL
cases, which is consonant with the optimal performance
of screening in daily routine. Conversely, the equivocal
alterations were inadequately identiﬁed (14–31%). Indeed,
ASC-US is notoriously a poorly reproducible diagnostic
category. In fact, the equivocal smears are frequently
diagnosed as negative in RR, and only experienced pro-
fessionals are believed to reproduce more accurately this
unfortunate diagnostic category of TBS.15
The recommended screening interval of 2–3 yr by the
American College of Gynaecology and Obstetrics (ACGO)
necessitates the development of precise strategies how to
reduce the false-negative rates to increase the efﬁciency and
suitability of the Pap smear screening.16 We can conclude
that RR techniques can be applied in the Public Health Lab-
oratories and seem to offer good perspectives for improving
the results of cytological screening.
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Table VI. Reproducibility of the RR Techniques Analysed by j
Coefﬁcient
Technique Laboratory A Laboratory B Both
Whole þ Turret 0.27 (0.19–0.35) 0.28 (0.18–0.38) 0.28 (0.21–0.34)
Step þ Turret 0.32 (0.23–0.40) 0.27 (0.18–0.36) 0.30 (0.24–0.36)
Whole þ Step 0.28 (0.20–0.36) 0.33 (0.23–0.42) 0.30 (0.24–0.36)
Table V. Distribution of the Diagnoses With the Three RR Techniques
in Laboratory B
Final
diagnosis
Whole/Turret/Step–Laboratory B
Negative Suspicious
n % n %
Negative 874/883/871 96/98/96 33/19/32 4/2/3
LSIL 7/6/5 64/54/45 4/5/6 36/45/54
HSIL 1/0/1 12/0/12 7/8/7 87/100/87
AGC 2/4/2 50/100/50 2/0/2 50/0/50
ASC-US 25/29/22 76/88/67 8/4/11 24/12/33
ASC-H –a –a 1/1/1 100
aThe three techniques detected all ASC-H cases in the Laboratory B.
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